Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis

BACKGROUND: Interleukin 2 (IL-2) is a cytokine secreted by activated T cells. Studies exploring recombinant human interleukin 2 (rhuIL-2) as an adjunctive immunotherapeutic agent to treat tuberculosis (TB) have shown variable results; however, the true therapeutic efficacy of rhuIL-2 administration...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ruimei, Xi, Xiangyu, Wang, Chunying, Pan, Yong, Ge, Changhua, Zhang, Liying, Zhang, Shuo, Liu, Huimei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053227/
https://www.ncbi.nlm.nih.gov/pubmed/30024982
http://dx.doi.org/10.1371/journal.pone.0201025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053227/
https://www.ncbi.nlm.nih.gov/pubmed/30024982
http://dx.doi.org/10.1371/journal.pone.0201025

Ejemplares similares